{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.1050","meta":{"versionId":"5","lastUpdated":"2022-03-01T16:18:11.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2022-03-01"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1050","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.1050"}],"version":"20210909","name":"Antispasmodics","title":"Antispasmodics","status":"active","experimental":false,"date":"2021-09-09T01:01:05-04:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to represent concepts for antispasmodic medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes atropine (excluding ophthalmic), belladonna alkaloids, chlordiazepoxide- clidinium, dicyclomine, hyoscyamine, methscopolamine, propantheline and scopolamine. Includes concepts that represent generic, human use and prescribable medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients.)","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1502"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1520"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1276"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1506"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1508"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1534"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1526"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1527"]}]},"expansion":{"identifier":"urn:uuid:c903dcc9-1500-4393-9a80-f9ff15985c90","timestamp":"2023-12-11T02:05:01-05:00","total":47,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1037234","display":"benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1046770","display":"12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1046787","display":"atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1046815","display":"atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1046982","display":"hyoscyamine sulfate 0.125 MG Sublingual Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1046985","display":"hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1046997","display":"atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1047786","display":"hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1047881","display":"hyoscyamine sulfate 0.025 MG/ML Oral Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1047895","display":"hyoscyamine sulfate 0.125 MG/ML Oral Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1047905","display":"hyoscyamine sulfate 0.125 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1047916","display":"1 ML hyoscyamine sulfate 0.5 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1048124","display":"12 HR atropine sulfate 0.04 MG / chlorpheniramine maleate 8 MG / hyoscyamine sulfate 0.19 MG / pseudoephedrine hydrochloride 90 MG / scopolamine hydrobromide 0.01 MG Extended Release Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1048307","display":"hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1048336","display":"hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1050325","display":"hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1087365","display":"hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1190538","display":"0.7 ML atropine sulfate 0.714 MG/ML Auto-Injector"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1190540","display":"0.7 ML atropine sulfate 1.43 MG/ML Auto-Injector"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1190542","display":"0.7 ML atropine sulfate 2.86 MG/ML Auto-Injector"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1190546","display":"10 ML atropine sulfate 0.1 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1190551","display":"5 ML atropine sulfate 0.05 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1190552","display":"5 ML atropine sulfate 0.1 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1190568","display":"atropine sulfate 0.005 MG/ML / diphenoxylate hydrochloride 0.5 MG/ML Oral Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1190572","display":"atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1190738","display":"atropine sulfate 0.025 MG / difenoxin hydrochloride 1 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1190748","display":"5 ML atropine sulfate 0.14 MG/ML / edrophonium chloride 10 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1190776","display":"atropine sulfate 0.4 MG/ML Injectable Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1190793","display":"0.5 ML atropine sulfate 0.8 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1190795","display":"1 ML atropine sulfate 1 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1440869","display":"hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1666781","display":"1 ML atropine sulfate 0.4 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1807886","display":"Biphasic 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"198165","display":"propantheline 15 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"198207","display":"scopolamine 0.4 MG/ML Injectable Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"226552","display":"72 HR scopolamine 0.0139 MG/HR Transdermal System"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"312104","display":"belladonna alkaloids 16.2 MG / opium 30 MG Rectal Suppository"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"312107","display":"belladonna alkaloids 16.2 MG / opium 60 MG Rectal Suppository"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"314088","display":"methscopolamine bromide 2.5 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"403914","display":"methscopolamine bromide 5 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"727415","display":"2.7 ML atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML Auto-Injector"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"889614","display":"chlordiazepoxide hydrochloride 5 MG / clidinium bromide 2.5 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"991061","display":"dicyclomine hydrochloride 10 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"991065","display":"2 ML dicyclomine hydrochloride 10 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"991082","display":"dicyclomine hydrochloride 2 MG/ML Oral Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"991086","display":"dicyclomine hydrochloride 20 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"998726","display":"hyoscyamine sulfate 0.0625 MG / phenyltoloxamine citrate 15 MG Oral Capsule"}]}}